To enhance the submission process, Malaysia NPRA has developed a screening package for New Drug Products and Biologics to provide clearer guidance and promote Good Submission Practice.
This tool is designed to ensure that applicant dossiers are complete and meet the necessary regulatory requirements prior to submission.
For more information you may access through the link: